Summit Partners Public Asset Management, LLC Beam Therapeutics Inc. Transaction History
Summit Partners Public Asset Management, LLC
- $2.79 Billion
- Q3 2024
A detailed history of Summit Partners Public Asset Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 100,000 shares of BEAM stock, worth $2.74 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$2.74 Million% of portfolio
0.1%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BEAM
# of Institutions
240Shares Held
76.3MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$225 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$215 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$209 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$194 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$133 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.93B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...